The Tri-State Experience: Outcome Analysis of Patients with Triple Negative Breast Cancer Treated at Marshall University

Authors

Laurie Matt MD, MPH, Marshall UniversityFollow
Mohammad Mozayen MD, Marshall UniversityFollow
Todd W. Gress MD, Marshall UniversityFollow
Maria Tria Tirona MD, Marshall UniverisityFollow

Document Type

Article

Publication Date

Fall 9-2015

Abstract

Breast cancer is the most frequently diagnosed malignancy in women in the United States. It is the second most common malignancy to cause death, with approximately 39,000 women dying of breast cancer in the United States in 2013. Triple negative breast cancer is defined as the absence of estrogen, progesterone and human epidermal growth factor receptor 2 receptors. It has been associated with a higher incidence in African American women, a younger age and a more advanced stage at diagnosis, and an inferior overall survival. To recognize the differences of our West Virginia community population when compared to the national average, we conducted a retrospective review of all patients diagnosed with breast cancer from 2000-2012.

Comments

The copy of record is available from the publisher at http://www.wvsma.org/Journal/PastEditionsoftheJournal.aspx. Copyright © 2014 West Virginia State Medical Association. Reprinted with permission. All rights reserved.

Recommended Citation

Matt L, Mozayen M, Gress T, Tirona MT. The Tri-State experience: Outcome analysis of patients with triple negative breast cancer treated at Marshall University. West Virginia Medical Journal. 2015;111(5):30-5.